G. Michael Bright

1.3k total citations
9 papers, 936 citations indexed

About

G. Michael Bright is a scholar working on Organic Chemistry, Pharmacology and Molecular Medicine. According to data from OpenAlex, G. Michael Bright has authored 9 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Pharmacology and 3 papers in Molecular Medicine. Recurrent topics in G. Michael Bright's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Cancer therapeutics and mechanisms (1 paper). G. Michael Bright is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Cancer therapeutics and mechanisms (1 paper). G. Michael Bright collaborates with scholars based in United States. G. Michael Bright's co-authors include Richard E. Isaacson, M F Newborg, Ronald P. Gladue, Barry M. Trost, MARY MANOUSOS, Agnès Girard, MARGARET R. ANDERSON, James A. Retsema, Charles R. Frihart and David R. Brittelli and has published in prestigious journals such as Journal of the American Chemical Society, Antimicrobial Agents and Chemotherapy and Tetrahedron Letters.

In The Last Decade

G. Michael Bright

9 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Michael Bright United States	5	388	230	180	162	155	9	936
A. Percival United Kingdom	19	520 1.3×	156 0.7×	124 0.7×	152 0.9×	141 0.9×	49	1.3k
N. L. Shipkowitz United States	19	484 1.2×	239 1.0×	239 1.3×	173 1.1×	136 0.9×	29	1.0k
S. R. M. Bushby United Kingdom	19	535 1.4×	444 1.9×	291 1.6×	371 2.3×	179 1.2×	40	1.4k
Roy Cleeland United States	21	256 0.7×	307 1.3×	159 0.9×	249 1.5×	112 0.7×	66	1.2k
A. R. English United States	16	283 0.7×	520 2.3×	242 1.3×	395 2.4×	209 1.3×	45	1.3k
K. W. Brammer United Kingdom	17	644 1.7×	175 0.8×	744 4.1×	63 0.4×	108 0.7×	35	1.3k
Paul Stevens United States	21	357 0.9×	150 0.7×	315 1.8×	105 0.6×	50 0.3×	65	1.6k
Ron Boon United States	19	1.0k 2.6×	315 1.4×	291 1.6×	113 0.7×	57 0.4×	36	1.6k
F J Silverblatt United States	21	344 0.9×	256 1.1×	240 1.3×	142 0.9×	22 0.1×	36	1.5k
Horatio B. Fung United States	20	445 1.1×	257 1.1×	719 4.0×	130 0.8×	150 1.0×	27	1.6k

Countries citing papers authored by G. Michael Bright

Since Specialization

Citations

This map shows the geographic impact of G. Michael Bright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Michael Bright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Michael Bright more than expected).

Fields of papers citing papers by G. Michael Bright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Michael Bright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Michael Bright. The network helps show where G. Michael Bright may publish in the future.

Co-authorship network of co-authors of G. Michael Bright

This figure shows the co-authorship network connecting the top 25 collaborators of G. Michael Bright. A scholar is included among the top collaborators of G. Michael Bright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Michael Bright. G. Michael Bright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Gladue, Ronald P., G. Michael Bright, Richard E. Isaacson, & M F Newborg. (1989). In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells. Antimicrobial Agents and Chemotherapy. 33(3). 3 indexed citations

Gladue, Ronald P., G. Michael Bright, Richard E. Isaacson, & M F Newborg. (1989). In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrobial Agents and Chemotherapy. 33(3). 277–282. 409 indexed citations

Retsema, James A., et al.. (1987). Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrobial Agents and Chemotherapy. 31(12). 1939–1947. 375 indexed citations

Bright, G. Michael, et al.. (1984). Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives. Antimicrobial Agents and Chemotherapy. 25(1). 113–117. 3 indexed citations

Kellogg, Michael S., G. Michael Bright, & Michael F. Dee. (1980). Synthesis of a Novel b-Lactam Containing Nucleus: 1-Carboxy-2-aza-tricyclic[4.2.2.02,5]decan-3-one. Heterocycles. 14(9). 1251–1251. 3 indexed citations

Trost, Barry M., et al.. (1973). Pyracylene dianions. Tetrahedron Letters. 14(29). 2787–2790. 11 indexed citations

Trost, Barry M., G. Michael Bright, Charles R. Frihart, & David R. Brittelli. (1971). Perturbed [12]annulenes. Synthesis of pyracylenes. Journal of the American Chemical Society. 93(3). 737–745. 82 indexed citations

Trost, Barry M. & G. Michael Bright. (1969). Novel reduction by diiron nonacarbonyl. Journal of the American Chemical Society. 91(13). 3689–3690. 4 indexed citations

Trost, Barry M. & G. Michael Bright. (1967). Pyracylene. Pentalenoid system. Journal of the American Chemical Society. 89(16). 4244–4245. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact